J Neurol Surg B Skull Base 2023; 84(06): 567-577
DOI: 10.1055/a-1934-9377
Original Article

Assessing Quality of Life among Radiation-Induced Hypopituitary Patients

1   University of Michigan Medical School, Office of Medical Student Education, Ann Arbor, Michigan, United States
,
Emily L. Bellile
2   Department of Biostatistics, University of Michigan, Ann Arbor, Michigan, United States
,
Kyle K. VanKoevering
3   Department of Otolaryngology, Ohio State University, Columbus, Ohio, United States
,
Erin L. McKean
4   Department of Otolaryngology Head and Neck Surgery, Michigan Medicine, University of Michigan, Ann Arbor, Michigan, United States
› Institutsangaben
Funding C. Yoonhee Ryder is supported by a TL-1 training grant (NIH; 5 TL1 TR002242–05).

Abstract

Introduction Radiation-induced hypopituitarism (RIH) has long been recognized as one of the deleterious side effects of skull base radiation. This study aims to assess the quality of life (QoL) among patients with RIH compared with radiated patients who did not develop hypopituitarism using the validated Anterior Skull Base Questionnaire (ASBQ).

Methods This was a single-institution retrospective cohort study. Included patients had a history of anterior skull base tumor, underwent at least one round of radiation to the skull base, and had filled out at least one ASBQ survey after their radiation treatment. Three statistical models were used to determine the effect of hypopituitarism and treatment on QoL scores.

Results A total of 145 patients met inclusion criteria, and 330 ASBQ surveys were analyzed. Thirty-five percent (51/145) had evidence of RIH at some point after their radiation treatment. Those with hypopituitarism had significantly lower overall ASBQ scores across all three models even after adjusting for potential confounders and intraperson correlation (average decrease of 0.24–0.45 on a 5-point Likert scale; p-values ranging from 0.0004 to 0.018). The increase in QoL with hormonal replacement was modulated by time out from radiation, with long-term survivors (5+ years out from radiation) gaining the most benefit from treatment (increase of 0.89 on a 5-point Likert scale, p 0.0412), especially in the vitality domain.

Conclusion This data demonstrates that hypopituitarism is an independent predictor of lower QoL. Early detection and appropriate treatment are essential to avoid the negative impact of hypopituitarism on QoL.



Publikationsverlauf

Eingereicht: 14. Mai 2022

Angenommen: 29. August 2022

Accepted Manuscript online:
31. August 2022

Artikel online veröffentlicht:
10. Oktober 2022

© 2022. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • References

  • 1 Lam KS, Tse VK, Wang C, Yeung RT, Ho JH. Effects of cranial irradiation on hypothalamic-pituitary function–a 5-year longitudinal study in patients with nasopharyngeal carcinoma. Q J Med 1991; 78 (286) 165-176
  • 2 Löfdahl E, Berg G, Johansson KA. et al. Compromised quality of life in adult patients who have received a radiation dose towards the basal part of the brain. A case-control study in long-term survivors from cancer in the head and neck region. Radiat Oncol 2012; 7: 179
  • 3 Fernandez A, Brada M, Zabuliene L, Karavitaki N, Wass JA. Radiation-induced hypopituitarism. Endocr Relat Cancer 2009; 16 (03) 733-772
  • 4 Darzy KH, Shalet SM. Hypopituitarism following radiotherapy. Pituitary 2009; 12 (01) 40-50
  • 5 VanKoevering KK, Sabetsarvestani K, Sullivan SE, Barkan A, Mierzwa M, McKean EL. Pituitary dysfunction after radiation for anterior skull base malignancies: incidence and screening. J Neurol Surg B Skull Base 2020; 81 (01) 75-81
  • 6 Darzy KH. Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Clin Pract Endocrinol Metab 2009; 5 (02) 88-99
  • 7 Agha A, Sherlock M, Brennan S. et al. Hypothalamic-pituitary dysfunction after irradiation of nonpituitary brain tumors in adults. J Clin Endocrinol Metab 2005; 90 (12) 6355-6360
  • 8 Ratnasingam J, Karim N, Paramasivam SS. et al. Hypothalamic pituitary dysfunction amongst nasopharyngeal cancer survivors. Pituitary 2015; 18 (04) 448-455
  • 9 Ipekci SH, Cakir M, Kiyici A, Koc O, Artac M. Radiotherapy-induced hypopituitarism in nasopharyngeal carcinoma: the tip of an iceberg. Exp Clin Endocrinol Diabetes 2015; 123 (07) 411-418
  • 10 Constine LS, Woolf PD, Cann D. et al. Hypothalamic-pituitary dysfunction after radiation for brain tumors. N Engl J Med 1993; 328 (02) 87-94
  • 11 Vakilian S, Thébaut J, Ruo R. et al. Examination of the dose-effect relationship of radiation-induced hypopituitarism: results of a case-control study. Adv Radiat Oncol 2021; 6 (04) 100693
  • 12 Kirkman MA, Borg A, Al-Mousa A, Haliasos N, Choi D. Quality-of-life after anterior skull base surgery: a systematic review. J Neurol Surg B Skull Base 2014; 75 (02) 73-89
  • 13 Gil Z, Abergel A, Spektor S, Shabtai E, Khafif A, Fliss DM. Development of a cancer-specific anterior skull base quality-of-life questionnaire. J Neurosurg 2004; 100 (05) 813-819
  • 14 Gil Z, Abergel A, Spektor S. et al. Quality of life following surgery for anterior skull base tumors. Arch Otolaryngol Head Neck Surg 2003; 129 (12) 1303-1309
  • 15 Ajmal A, McKean E, Sullivan S, Barkan A. Decreased quality of life (QoL) in hypopituitary patients: involvement of glucocorticoid replacement and radiation therapy. Pituitary 2018; 21 (06) 624-630
  • 16 Abergel A, Cavel O, Margalit N, Fliss DM, Gil Z. Comparison of quality of life after transnasal endoscopic vs open skull base tumor resection. Arch Otolaryngol Head Neck Surg 2012; 138 (02) 142-147
  • 17 Fliss DM, Abergel A, Cavel O, Margalit N, Gil Z. Combined subcranial approaches for excision of complex anterior skull base tumors. Arch Otolaryngol Head Neck Surg 2007; 133 (09) 888-896
  • 18 McCoul ED, Anand VK, Schwartz TH. Improvements in site-specific quality of life 6 months after endoscopic anterior skull base surgery: a prospective study. J Neurosurg 2012; 117 (03) 498-506
  • 19 McCoul ED, Anand VK, Bedrosian JC, Schwartz TH. Endoscopic skull base surgery and its impact on sinonasal-related quality of life. Int Forum Allergy Rhinol 2012; 2 (02) 174-181
  • 20 Crespo I, Santos A, Webb SM. Quality of life in patients with hypopituitarism. Curr Opin Endocrinol Diabetes Obes 2015; 22 (04) 306-312
  • 21 Rosén T, Wirén L, Wilhelmsen L, Wiklund I, Bengtsson BA. Decreased psychological well-being in adult patients with growth hormone deficiency. Clin Endocrinol (Oxf) 1994; 40 (01) 111-116
  • 22 Erfurth EM, Holmer H, Fjalldal SB. Mortality and morbidity in adult craniopharyngioma. Pituitary 2013; 16 (01) 46-55
  • 23 Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research Electronic Data Capture (REDCap)–a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform 2009; 42 (02) 377-381
  • 24 Kheterpal S. Data Direct: a self-serve tool for data retrieval. University of Michigan Medical School Office of Research. 2022 . Available at: https://research.medicine.umich.edu/sites/default/files/doctr_datadirect_user_guide_2019-10-03.pdf , 22 Nov 2016
  • 25 Erturk E, Jaffe CA, Barkan AL. Evaluation of the integrity of the hypothalamic-pituitary-adrenal axis by insulin hypoglycemia test. J Clin Endocrinol Metab 1998; 83 (07) 2350-2354
  • 26 Norman GR, Sloan JA, Wyrwich KW. Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41 (05) 582-592
  • 27 Jasim S, Alahdab F, Ahmed AT. et al. Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine 2017; 56 (01) 33-42
  • 28 Castinetti F. Radiation techniques in aggressive pituitary tumours and carcinomas. Rev Endocr Metab Disord 2020; 21 (02) 287-292
  • 29 Sathyapalan T, Dixit S. Radiotherapy-induced hypopituitarism: a review. Expert Rev Anticancer Ther 2012; 12 (05) 669-683
  • 30 Darzy KH. Radiation-induced hypopituitarism. Curr Opin Endocrinol Diabetes Obes 2013; 20 (04) 342-353
  • 31 Littley MD, Shalet SM, Beardwell CG, Ahmed SR, Applegate G, Sutton ML. Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 1989; 70 (262) 145-160
  • 32 Minniti G, Gilbert DC, Brada M. Modern techniques for pituitary radiotherapy. Rev Endocr Metab Disord 2009; 10 (02) 135-144
  • 33 Höybye C, Grenbäck E, Rähn T, Degerblad M, Thorén M, Hulting AL. Adrenocorticotropic hormone-producing pituitary tumors: 12- to 22-year follow-up after treatment with stereotactic radiosurgery. Neurosurgery 2001; 49 (02) 284-291 , discussion 291–292
  • 34 Chan LF, Storr HL, Plowman PN. et al. Long-term anterior pituitary function in patients with paediatric Cushing's disease treated with pituitary radiotherapy. Eur J Endocrinol 2007; 156 (04) 477-482
  • 35 Mitsumori M, Shrieve DC, Alexander III E. et al. Initial clinical results of LINAC-based stereotactic radiosurgery and stereotactic radiotherapy for pituitary adenomas. Int J Radiat Oncol Biol Phys 1998; 42 (03) 573-580
  • 36 Pfister DG, Spencer S, Adelstein D. et al. Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 2020; 18 (07) 873-898
  • 37 Isaksson S, Bogefors K, Ståhl O. et al. High risk of hypogonadism in young male cancer survivors. Clin Endocrinol (Oxf) 2018; 88 (03) 432-441